Drug Database
Back to search

Netherlands· NL-adf5cebe6740

Pamipro 3 mg/ml, concentraat voor oplossing voor infusie

A pamidronic acid product containing dinatriumpamidronaat 0-water, registered in Netherlands by Medac Gesellschaft für klinische Spezialpräparate mbH. The same ATC class is registered in 8 of our 19 countries.

ATC M05BA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPamipro 3 mg/ml, concentraat voor opl…ATCM05BA03REGISTER NO.NL-adf5cebe6740PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dinatriumpamidronaat 0-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pamidronic acid is registered in 8 of 19 countries.

Countries holding a registration under ATC M05BA03 (pamidronic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search pamidronic acid products by name

Pamidronic acid · ATC M05BA03

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DINATRIUMPAMIDRONAAT 0-WATER
Manufacturer
Medac Gesellschaft für klinische Spezialpräparate mbH
Country
Netherlands (NL)
ATC code
M05BA03
ATC class
Pamidronic acid
Defined daily dose
60 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    30331

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

220 interactions on record for pamidronic acid.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pamidronic acid against other medicinesHow interaction checks work

Pamidronic acid · interactions on record

220 records

  • 12 severe
  • 57 moderate
  • 151 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • SirolimusL01EG04severe
  • SirolimusL04AA10severe
  • TacrolimusL04AD02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pamidronic acid in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pamidronic acid products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • France · Pamidronate De Sodium Hospira
  • Portugal · Pamidronato Hikma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff55443d-7e73-4c39-8aba-e8b550520282
GET /v1/drugs/ff55443d-7e73-4c39-8aba-e8b550520282?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h30331_smpc.pdf",
  "strength": null,
  "atc_label": "Pamidronic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg30331",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "DINATRIUMPAMIDRONAAT 0-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h30331.pdf",
  "authorised_at": "2005/05/13",
  "procedure_number": "FI/H/0263/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "30331",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about pamidronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console